Back

Stem cell control and cancer initiation by an autocrine, injury-activated Igf complex

Zhang, Y.; Ouadah, Y.; Liu, Y.; Kumar, M.; Morck, M.; Krasnow, M. A.

2026-02-04 cell biology
10.64898/2026.02.02.703150 bioRxiv
Show abstract

Stem cells rapidly proliferate after injury to repair damaged tissue, and chronic injury predisposes to cancer. However, injury-activated mitogens, the mechanisms that keep them inactive until injury, and their role in cancer are not understood. Here we identify Igf2 as the injury-activated mitogen for neuroendocrine stem cells, a facultative airway stem cell and origin of small cell lung cancer. Igf2 is constitutively produced by the stem cells but sequestered in inactive form by co-expressed Igf binding proteins. Injury releases Igf2 and induces proliferation by activating its receptors and repressing Rb tumor suppressor, which normally enforces stem cell quiescence. Persistent pathway activation initiates oncogenesis. Thus, in addition to its classical hormonal roles in physiology, growth, and aging, Igf operates locally with Igf binding proteins and Rb to control injury-induced stem cell activation and cancer. This pathway may also control related stem cells and cancers of the body and brain.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
eLife
● 5828 papers in training set
Top 9%
11.5%
Similar papers in this journal
2
Science Advances
● 1243 papers in training set
Top 0.9%
11.5%
Similar papers in this journal
3
Science
● 477 papers in training set
Top 0.8%
8.6%
Similar papers in this journal
4
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 6%
7.0%
Similar papers in this journal
5
Cell Stem Cell
○ 62 papers in training set
Top 0.2%
7.0%
Similar papers in this journal
6
Nature Communications
○ 5641 papers in training set
Top 26%
6.0%
50% of probability mass above
7
Cell Reports
○ 1498 papers in training set
Top 8%
4.7%
8
Developmental Cell
○ 196 papers in training set
Top 0.9%
4.2%
9
JCI Insight
● 277 papers in training set
Top 3%
3.0%
10
Nature
○ 645 papers in training set
Top 5%
2.7%
11
Cancer Discovery
● 66 papers in training set
Top 0.9%
2.5%
12
Nature Cell Biology
○ 118 papers in training set
Top 1%
2.4%
13
American Journal of Respiratory Cell and Molecular Biology
◐ 43 papers in training set
Top 0.4%
1.8%
14
Journal of Clinical Investigation
● 179 papers in training set
Top 3%
1.8%
15
Cell
○ 431 papers in training set
Top 6%
1.8%
16
Science Immunology
● 88 papers in training set
Top 2%
1.4%
17
The EMBO Journal
○ 309 papers in training set
Top 4%
1.3%
18
Molecular Cell
○ 350 papers in training set
Top 4%
1.3%
19
Cell Metabolism
○ 57 papers in training set
Top 1%
1.1%
20
iScience
○ 1154 papers in training set
Top 29%
1.1%
21
American Journal of Respiratory and Critical Care Medicine
◐ 43 papers in training set
Top 0.8%
1.0%
22
Current Biology
○ 665 papers in training set
Top 11%
0.8%
23
Journal of Experimental Medicine
● 119 papers in training set
Top 3%
0.8%
24
Nature Immunology
○ 79 papers in training set
Top 2%
0.8%
25
Gastroenterology
○ 42 papers in training set
Top 1%
0.8%
26
Cancer Research
● 130 papers in training set
Top 3%
0.8%
27
Immunity
○ 67 papers in training set
Top 2%
0.8%
28
Science Translational Medicine
● 127 papers in training set
Top 4%
0.8%
29
PLOS Biology
● 486 papers in training set
Top 12%
0.8%
30
Journal of Cell Biology
● 392 papers in training set
Top 5%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.